Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$25.16 - $28.86 $22,090 - $25,339
-878 Reduced 3.03%
28,114 $730,000
Q1 2023

May 11, 2023

BUY
$25.91 - $32.1 $22,800 - $28,248
880 Added 3.13%
28,992 $832,000
Q4 2022

Feb 13, 2023

SELL
$23.85 - $31.91 $5,724 - $7,658
-240 Reduced 0.85%
28,112 $832,000
Q3 2022

Nov 14, 2022

BUY
$21.74 - $24.68 $308,925 - $350,702
14,210 Added 100.48%
28,352 $675,000
Q2 2022

Aug 12, 2022

SELL
$20.4 - $25.53 $316,179 - $395,689
-15,499 Reduced 52.29%
14,142 $316,000
Q1 2022

May 13, 2022

BUY
$24.7 - $36.54 $157,166 - $232,504
6,363 Added 27.33%
29,641 $744,000
Q4 2021

Feb 10, 2022

BUY
$35.83 - $45.03 $307,636 - $386,627
8,586 Added 58.44%
23,278 $834,000
Q3 2021

Nov 10, 2021

SELL
$38.75 - $44.47 $233,468 - $267,931
-6,025 Reduced 29.08%
14,692 $625,000
Q2 2021

Aug 10, 2021

SELL
$39.42 - $48.08 $306,451 - $373,773
-7,774 Reduced 27.29%
20,717 $897,000
Q1 2021

May 10, 2021

BUY
$32.49 - $45.96 $750,908 - $1.06 Million
23,112 Added 429.67%
28,491 $1.16 Million
Q4 2020

Feb 10, 2021

SELL
$32.59 - $45.26 $212,226 - $294,733
-6,512 Reduced 54.76%
5,379 $243,000
Q3 2020

Nov 13, 2020

BUY
$32.56 - $38.57 $148,115 - $175,454
4,549 Added 61.96%
11,891 $421,000
Q2 2020

Aug 07, 2020

BUY
$27.83 - $37.73 $204,327 - $277,013
7,342 New
7,342 $277,000
Q1 2020

May 15, 2020

SELL
$22.38 - $54.06 $418,931 - $1.01 Million
-18,719 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$51.85 - $73.36 $269,205 - $380,885
-5,192 Reduced 21.71%
18,719 $971,000
Q3 2019

Nov 14, 2019

BUY
$40.05 - $57.47 $45,857 - $65,803
1,145 Added 5.03%
23,911 $1.31 Million
Q2 2019

Aug 09, 2019

BUY
$30.3 - $41.14 $63,872 - $86,723
2,108 Added 10.2%
22,766 $925,000
Q1 2019

May 15, 2019

BUY
$29.37 - $40.49 $606,725 - $836,442
20,658 New
20,658 $625,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $236M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.